These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 39285385)

  • 1. The Abl1 tyrosine kinase is a key player in doxorubicin-induced cardiomyopathy and its p53/p73 cell death mediated signaling differs in atrial and ventricular cardiomyocytes.
    Borlak J; Ciribilli Y; Bisio A; Selvaraj S; Inga A; Oh JH; Spanel R
    J Transl Med; 2024 Sep; 22(1):845. PubMed ID: 39285385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function.
    Wang P; Wang L; Lu J; Hu Y; Wang Q; Li Z; Cai S; Liang L; Guo K; Xie J; Wang J; Lan R; Shen J; Liu P
    J Mol Cell Cardiol; 2019 Aug; 133():125-137. PubMed ID: 31199952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Protect Cardiomyocytes from Doxorubicin-Induced Cardiomyopathy by Upregulating Survivin Expression via the miR-199a-3p-Akt-Sp1/p53 Signaling Pathway.
    Lee JY; Chung J; Byun Y; Kim KH; An SH; Kwon K
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes.
    Liu J; Mao W; Ding B; Liang CS
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H1956-65. PubMed ID: 18775851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 prevents doxorubicin cardiotoxicity independently of its prototypical tumor suppressor activities.
    Li J; Wang PY; Long NA; Zhuang J; Springer DA; Zou J; Lin Y; Bleck CKE; Park JH; Kang JG; Hwang PM
    Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19626-19634. PubMed ID: 31488712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of a GATA4/Ankrd1 signaling axis in cardiomyocytes leads to sarcomere disarray: implications for anthracycline cardiomyopathy.
    Chen B; Zhong L; Roush SF; Pentassuglia L; Peng X; Samaras S; Davidson JM; Sawyer DB; Lim CC
    PLoS One; 2012; 7(4):e35743. PubMed ID: 22532871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
    Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
    Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protective role of arjunolic acid against doxorubicin induced intracellular ROS dependent JNK-p38 and p53-mediated cardiac apoptosis.
    Ghosh J; Das J; Manna P; Sil PC
    Biomaterials; 2011 Jul; 32(21):4857-66. PubMed ID: 21486680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal shock waves protect cardiomyocytes from doxorubicin-induced cardiomyopathy by upregulating survivin via the integrin-ILK-Akt-Sp1/p53 axis.
    Yoon Lee J; Chung J; Hwa Kim K; Hyun An S; Yi JE; Ae Kwon K; Kwon K
    Sci Rep; 2019 Aug; 9(1):12149. PubMed ID: 31434946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follistatin-like protein 1 attenuates doxorubicin-induced cardiomyopathy by inhibiting MsrB2-mediated mitophagy.
    Lu L; Shao Y; Wang N; Xiong X; Zhai M; Tang J; Liu Y; Yang J; Yang L
    Mol Cell Biochem; 2024 Jul; 479(7):1817-1831. PubMed ID: 38696001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klotho attenuated Doxorubicin-induced cardiomyopathy by alleviating Dynamin-related protein 1 - mediated mitochondrial dysfunction.
    Zhuang X; Sun X; Zhou H; Zhang S; Zhong X; Xu X; Guo Y; Xiong Z; Liu M; Lin Y; Zhang M; Liao X
    Mech Ageing Dev; 2021 Apr; 195():111442. PubMed ID: 33539906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated cardiomyocyte senescence contributes to late-onset doxorubicin-induced cardiotoxicity.
    Mitry MA; Laurent D; Keith BL; Sira E; Eisenberg CA; Eisenberg LM; Joshi S; Gupte S; Edwards JG
    Am J Physiol Cell Physiol; 2020 Feb; 318(2):C380-C391. PubMed ID: 31913702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cyclin-dependent kinase 7 mitigates doxorubicin cardiotoxicity and enhances anticancer efficacy.
    Chen J; Wei J; Xia P; Liu Y; Belew MD; Toohill R; Wu BJ; Cheng Z
    Cardiovasc Res; 2024 Jul; 120(9):1024-1036. PubMed ID: 38646672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-TEA cooperates with chemotherapeutic agents to induce apoptosis of p53 mutant, triple-negative human breast cancer cells via activating p73.
    Tiwary R; Yu W; Sanders BG; Kline K
    Breast Cancer Res; 2011 Jan; 13(1):R1. PubMed ID: 21214929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of doxorubicin-induced cardiomyopathy using targeted MaFGF mediated by nanoparticles combined with ultrasound-targeted MB destruction.
    Tian XQ; Ni XW; Xu HL; Zheng L; ZhuGe DL; Chen B; Lu CT; Yuan JJ; Zhao YZ
    Int J Nanomedicine; 2017; 12():7103-7119. PubMed ID: 29026304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin-induced p53 interferes with mitophagy in cardiac fibroblasts.
    Mancilla TR; Davis LR; Aune GJ
    PLoS One; 2020; 15(9):e0238856. PubMed ID: 32960902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired NF-κB signalling underlies cyclophilin D-mediated mitochondrial permeability transition pore opening in doxorubicin cardiomyopathy.
    Dhingra R; Guberman M; Rabinovich-Nikitin I; Gerstein J; Margulets V; Gang H; Madden N; Thliveris J; Kirshenbaum LA
    Cardiovasc Res; 2020 May; 116(6):1161-1174. PubMed ID: 31566215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death.
    Venkatesan B; Prabhu SD; Venkatachalam K; Mummidi S; Valente AJ; Clark RA; Delafontaine P; Chandrasekar B
    Cell Signal; 2010 May; 22(5):809-20. PubMed ID: 20074638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manipulation of cardiac phosphatidylinositol 3-kinase (PI3K)/Akt signaling by apoptosis regulator through modulating IAP expression (ARIA) regulates cardiomyocyte death during doxorubicin-induced cardiomyopathy.
    Kitamura Y; Koide M; Akakabe Y; Matsuo K; Shimoda Y; Soma Y; Ogata T; Ueyama T; Matoba S; Yamada H; Ikeda K
    J Biol Chem; 2014 Jan; 289(5):2788-800. PubMed ID: 24338479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: Plausible roles of p53, MAPK and AKT pathways.
    Mantawy EM; Esmat A; El-Bakly WM; Salah ElDin RA; El-Demerdash E
    Sci Rep; 2017 Jul; 7(1):4795. PubMed ID: 28684738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.